Terpenicol Antifungal Solution Recalled for CGMP Deviations
Blaine Labs Inc is recalling Terpenicol (Undecylenic Acid) antifungal solution because the firm discontinued required stability testing for products still on the market within their expiration dates.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving CGMP deviations related to discontinued stability testing. The source text does not report any illnesses, injuries, or deaths, and the hazard is procedural/regulatory rather than an identified product contamination or defect. The recall is precautionary based on manufacturing compliance failures.
Plain-English summary
Blaine Labs Inc is recalling Terpenicol Antifungal Solution (Undecylenic Acid 25%, 1.0 Fl Oz / 29.6 mL) nationwide due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, the firm discontinued required stability testing for products that are still being distributed and remain within their expiration dates.
The recalled product includes 5,801 bottles with the following lot numbers and expiration dates: Lot BL3411R (Exp Date 06/08/2027), Lot BL3468 (Exp Date 03/07/2027), and Lot BL3535 (Exp Date 09/25/2027). The product was manufactured by Blaine Labs, Inc., located at 11037 Lockport Place, Santa Fe Springs, CA 90670 (NDC 63347-600-01).
Consumers who have purchased this product should stop using it. Contact your healthcare provider or pharmacist if you have questions or concerns.
The recalled product
- Product
- TERPENICOL (UNDECYLENIC ACID)
- Brand
- TERPENICOL
- Manufacturer
- Blaine Labs Inc
- Category
- Drug — OTC Antifungal
- Affected units
- 5,801
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lots BL3411R
- Exp Date 06/08/2027
- BL3468
- Exp Date 03/07/2027
- & BL3535
- Exp Date 09/25/2027.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 8 recalled by Blaine Labs Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same brand · TERPENICOL
- ModerateTERPENICOL Antifungal Cream Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-08
Same manufacturer · Blaine Labs Inc
See all →- ModerateRevitaderm Wound Care Benzalkonium Chloride OTC Drug Recall
FDA (Drugs) · 2026-07-08
- Moderatevite20 Antifungal Cream recalled due to stability testing deviations
FDA (Drugs) · 2026-07-08
- ModerateFungal Fusion antifungal kit recalled for discontinued stability testing
FDA (Drugs) · 2026-07-08
- ModerateTRIPENICOL S Antifungal Solution Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateTridergel Benzalkonium Chloride Wound Care Gel Recalled
FDA (Drugs) · 2026-07-08
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- SevereShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19